TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Belach Bioteknik AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
7,470
|
30,085
|
13,821 |
| Financial expenses |
35
|
36
|
11 |
| Earnings before taxes |
-1,998
|
5,372
|
44 |
| EBITDA |
-1,867
|
5,499
|
161 |
| Total assets |
11,578
|
13,449
|
18,802 |
| Current assets |
8,867
|
12,985
|
18,781 |
| Current liabilities |
1,648
|
2,263
|
12,401 |
| Equity capital |
9,604
|
10,567
|
6,401 |
| - share capital |
507
|
473
|
488 |
| Employees (average) |
5
|
5
|
6 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
83.0%
|
78.6%
|
34.0% |
| Turnover per employee |
1,494
|
6,017
|
2,304 |
| Profit as a percentage of turnover |
-26.7%
|
17.9%
|
0.3% |
| Return on assets (ROA) |
-17.0%
|
40.2%
|
0.3% |
| Current ratio |
538.0%
|
573.8%
|
151.4% |
| Return on equity (ROE) |
-20.8%
|
50.8%
|
0.7% |
| Change turnover |
-24,749
|
16,679
|
-2,616 |
| Change turnover % |
-77%
|
124%
|
-16% |
| Chg. No. of employees |
0
|
-1
|
0 |
| Chg. No. of employees % |
0%
|
-17%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.